Status:
ACTIVE_NOT_RECRUITING
Improving Care and Community Representation for Adolescents and Young Adults Living With HIV in West Africa
Lead Sponsor:
Institut de Recherche pour le Developpement
Collaborating Sponsors:
Sidaction
EXPERTISE FRANCE, Paris France
Conditions:
HIV Infections
Adolescent Behavior
Eligibility:
All Genders
15-24 years
Brief Summary
Context: HIV-positive young people aged 15 to 24 are a heterogeneous population in terms of gender, age, mode of transmission, sexual orientation and risk-taking. This most vulnerable age group is at ...
Detailed Description
Context: HIV-positive young people aged 15 to 24 are a heterogeneous population in terms of gender, age, mode of transmission, sexual orientation and risk-taking. This most vulnerable age group is at ...
Eligibility Criteria
Inclusion
- being HIV-infected
- aged 15 to 24 years
- on antiretroviral treatment
- HIV status disclosed
- caretaker's written consent (if \< 18 years)
- adolescent's written consent
Exclusion
- mental illness
Key Trial Info
Start Date :
April 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT05405322
Start Date
April 7 2021
End Date
December 31 2024
Last Update
June 28 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU CDG
Ouagadougou, Burkina Faso
2
CHU YO
Ouagadougou, Burkina Faso
3
Chnear Albert Royer
Dakar, Senegal, 00000
4
Centre hospitalier Roi Baudouin
Guédiawaye, Senegal